Company Filing History:
1 out of 33 
1 out of 5,089 
1 out of 54 
Years Active: 2025
Title: Innovations in Immunology: The Contributions of Guillaume Sarrabayrouse
Introduction
Guillaume Sarrabayrouse is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of immunology, particularly in the diagnosis and treatment of diseases related to T lymphocytes. His innovative approach has the potential to impact the lives of many patients suffering from inflammatory bowel diseases.
Latest Patents
Sarrabayrouse holds a patent for a method that involves determining the number, concentration, and proportion of T lymphocytes with a CD4CD8αα phenotype, which express CCR6 and/or CXCR6. This invention is crucial for diagnosing, prognosing outcomes, and predicting the risk of developing diseases related to a decrease of these specific T lymphocytes. The method is particularly relevant for patients with inflammatory bowel diseases, such as Crohn's disease, where T lymphocytes with a CD4CD8ααCCR6+ CXCR6+ phenotype are significantly decreased.
Career Highlights
Throughout his career, Sarrabayrouse has worked with prestigious research institutions, including the Institut National de la Santé et de la Recherche Médicale (INSERM) and the Centre National de la Recherche Scientifique (CNRS). His work has been instrumental in advancing the understanding of immune responses and developing targeted therapies.
Collaborations
Sarrabayrouse has collaborated with notable colleagues in the field, including Frédéric Altare and Harry Sokol. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Guillaume Sarrabayrouse's contributions to immunology through his innovative patent and collaborative efforts highlight the importance of research in developing effective treatments for diseases. His work continues to pave the way for advancements in medical science.